NK Cells Are Not Required for Spontaneous Autoimmune Diabetes in NOD Mice

被引:14
|
作者
Beilke, Joshua N. [1 ,2 ]
Meagher, Craig T. [3 ]
Hosiawa, Karoline [4 ]
Champsaur, Marine [1 ,2 ]
Bluestone, Jeffrey A. [5 ]
Lanier, Lewis L. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Proctor Fdn, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA USA
[5] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
来源
PLOS ONE | 2012年 / 7卷 / 04期
关键词
NATURAL-KILLER-CELLS; CENTRAL-NERVOUS-SYSTEM; AUTOREACTIVE T-CELLS; IFN-GAMMA; IMMUNITY; ACTIVATION; INDUCTION; MECHANISM; ARTHRITIS; SUBSETS;
D O I
10.1371/journal.pone.0036011
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NK cells have been shown to either promote or protect from autoimmune diseases. Several studies have examined the role of receptors preferentially expressed by NK cells in the spontaneous disease of NOD mice or the direct role of NK cells in acute induced disease models of diabetes. Yet, the role of NK cells in spontaneous diabetes has not been directly addressed. Here, we used the NOD.NK1.1 congenic mouse model to examine the role of NK cells in spontaneous diabetes. Significant numbers of NK cells were only seen in the pancreas of mice with disease. Pancreatic NK cells displayed an activated surface phenotype and proliferated more than NK cells from other tissues in the diseased mice. Nonetheless, depletion of NK cells had no effect on dendritic cell maturation or T cell proliferation. In spontaneous disease, the deletion of NK cells had no significant impact on disease onset. NK cells were also not required to promote disease induced by adoptively transferred pathogenic CD4(+) T cells. Thus, NK cells are not required for spontaneous autoimmune diabetes in NOD mice.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Islet regeneration during the reversal of autoimmune diabetes in NOD mice
    Kodama, S
    Kühtreiber, W
    Fujimura, S
    Dale, EA
    Faustman, DL
    SCIENCE, 2003, 302 (5648) : 1223 - 1227
  • [32] Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice
    Alkan, Manal
    Machavoine, Francois
    Rignault, Rachel
    Dam, Julie
    Dy, Michel
    Thieblemont, Nathalie
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [33] Vitamin D status and autoimmune diabetes in NOD/LtJ mice
    Zella, JB
    DeLuca, HF
    FASEB JOURNAL, 2001, 15 (05): : A959 - A959
  • [34] Autoimmune diabetes in NOD mice lacking L-selectin
    Ablamunits, V
    Leiter, EH
    DIABETES, 2000, 49 : A70 - A70
  • [35] Critical roles of TRAIL in autoimmune diabetes in NOD mice.
    Lamhamedi-Cherradi, SE
    Zheng, S
    Chen, YH
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S11 - S12
  • [36] Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice
    Gordon, EJ
    Wicker, LS
    Peterson, LB
    Serreze, DV
    Markees, TG
    Shultz, LD
    Rossini, AA
    Greiner, DL
    Mordes, JP
    DIABETES, 2005, 54 (01) : 107 - 115
  • [37] IA-2 is not required for the development of diabetes in NOD mice
    A. Kubosaki
    J. Miura
    Abner L. Notkins
    Diabetologia, 2004, 47 : 149 - 150
  • [38] Interleukin-13 prevents autoimmune diabetes in NOD mice
    Zaccone, P
    Phillips, J
    Conget, I
    Gomis, R
    Haskins, K
    Minty, A
    Bendtzen, K
    Cooke, A
    Nicoletti, F
    DIABETES, 1999, 48 (08) : 1522 - 1528
  • [39] IA-2 is not required for the development of diabetes in NOD mice
    Kubosaki, A
    Miura, J
    Notkins, AL
    DIABETOLOGIA, 2004, 47 (01) : 149 - 150
  • [40] A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice
    Alix Besançon
    Tania Goncalves
    Fabrice Valette
    Caroline Mary
    Bernard Vanhove
    Lucienne Chatenoud
    Sylvaine You
    Diabetologia, 2018, 61 : 1811 - 1816